Myriad Genetics, Inc. (MYGN)
NASDAQ: MYGN · Real-Time Price · USD
4.840
+0.010 (0.21%)
At close: Apr 28, 2026, 4:00 PM EDT
4.840
0.00 (0.00%)
After-hours: Apr 28, 2026, 6:43 PM EDT
Myriad Genetics Employees
Myriad Genetics had 2,700 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
2,700
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$305,370
Profits / Employee
-$135,519
Market Cap
457.10M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| NeoGenomics | 2,500 |
| OPKO Health | 2,275 |
| Fulgent Genetics | 1,315 |
| GeneDx Holdings | 1,300 |
| Castle Biosciences | 883 |
| CareDx | 765 |
| Burning Rock Biotech | 674 |
| FONAR | 535 |
MYGN News
- 2 hours ago - Myriad Genetics to Release First Quarter 2026 Financial Results on May 5, 2026 - GlobeNewsWire
- 12 days ago - Myriad Genetics to Deliver Six Abstracts, Including Two Podiums, at AACR 2026 - GlobeNewsWire
- 14 days ago - Myriad Genetics Expands Access for MyChoice Test to Prostate Cancer Patients in Japan - GlobeNewsWire
- 19 days ago - Myriad Genetics Underscores Commitment to Cancer Care Continuum with New Data Presentations at SGO Annual Meeting - GlobeNewsWire
- 6 weeks ago - Myriad Genetics Receives FDA Approval of the MyChoice CDx Test as the Companion Diagnostic for Zejula (niraparib) for Patients with Ovarian Cancer - GlobeNewsWire
- 7 weeks ago - Myriad Genetics Transcript: Leerink Global Healthcare Conference 2026 - Transcripts
- 2 months ago - Myriad Genetics Transcript: TD Cowen 46th Annual Health Care Conference - Transcripts
- 2 months ago - Myriad Genetics Earnings Call Transcript: Q4 2025 - Transcripts